Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:30:59 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:OPK from 2023-04-30 to 2024-04-29 - 25 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-28 08:00U:OPKNews ReleaseLabcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
2024-03-20 08:00U:OPKNews ReleaseEntera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
2024-03-05 08:52U:OPKNews ReleaseAIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
2024-02-28 09:31U:OPKNews ReleaseNextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
2024-02-27 16:05U:OPKNews ReleaseOPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
2024-02-22 16:05U:OPKNews ReleaseOPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
2024-02-05 08:09U:OPKNews ReleaseNextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China
2024-01-09 16:05U:OPKNews ReleaseOPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser ¢ € ™s Option to Purchase Additional Notes
2024-01-08 08:00U:OPKNews ReleaseOPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-04 23:31U:OPKNews ReleaseOPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
2024-01-03 17:06U:OPKNews ReleaseOPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
2023-11-28 07:00U:OPKNews ReleaseBioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
2023-11-07 06:45U:OPKNews ReleaseBioReference ‚ ® Signs On as the First Laboratory to Use MSK-ACCESS ‚ ® Powered with SOPHiA DDM ¢ „ ¢
2023-11-07 06:45U:OPKNews ReleaseBioReference ‚ ® Signs On as the First Laboratory to Use MSK-ACCESS ‚ ® Powered with SOPHiA DDM ¢ „ ¢
2023-11-06 16:05U:OPKNews ReleaseOPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
2023-11-02 10:00U:OPKNews ReleaseNew Clinical Data on OPKO Health ¢ € ™s RAYALDEE ‚ ® (ER Calcifediol) Presented at Kidney Week 2023
2023-10-31 08:00U:OPKNews ReleaseOPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
2023-10-25 16:25U:OPKNews ReleaseOPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
2023-10-12 14:45U:OPKNews ReleaseNextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global
2023-09-28 16:08U:OPKNews ReleaseModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
2023-09-12 08:31U:OPKNews ReleaseEntera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
2023-08-03 16:05U:OPKNews ReleaseOPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results
2023-07-25 16:05U:OPKNews ReleaseOPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
2023-06-28 06:45U:OPKNews ReleaseFDA Approves Pfizer ¢ € ™s NGENLA ¢ „ ¢, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
2023-05-03 16:05U:OPKNews ReleaseOPKO Health Reports First Quarter 2023 Business Highlights and Financial Results